BioClinica Inc (NASDAQ:BIOC) Investor Files Lawsuit to Halt Acquisition Attempt by JLL Partners
An investor in shares of BioClinica Inc (NASDAQ:BIOC) filed a lawsuit to halt the proposed takeover of BioClinica Inc by JLL Partners, Inc at $7.25 per NASDAQ:BIOC share.
View full press release